Home / Catalog / Drugs & devices
Drugs & devicesSource-backed product
IRA Maximum Fair Price (CMS-negotiated)
The maximum fair prices CMS has negotiated for selected high-cost drugs under the Inflation Reduction Act, effective 2026 and 2027. The first federally negotiated Medicare drug prices.
What Vlada adds: Preserves the publisher data, normalizes schema eras and identifiers, and connects the product to compatible healthcare entities with measured join coverage.
- rows
- 386
- rows
- datasets
- 1
- datasets
- cadence
- annual
- cadence
- coverage
- 2026-2027
- coverage
Publishers: Centers for Medicare & Medicaid Services
What's inside
Primary dataset
CMS Inflation-Reduction-Act negotiated maximum fair prices.
grain: One row per (NDC11, program_year) negotiated MFP.
386 rows